Jci_page_head_homepage_01 Jci_page_head_homepage_02
Caroline Cheng, Dennie Tempel, Rien van Haperen, Hetty C. de Boer, Dolf Segers, Martin Huisman, Anton Jan van Zonneveld, Pieter J.M. Leenen, Anton van der Steen, Patrick W. Serruys, Rini de Crom, Rob Krams
Published in Volume 117, Issue 3
J Clin Invest. 2007; 117(3):616–626 doi:10.1172/JCI28180
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 9
Fractalkine function was inhibited during atherosclerosis development in the BCAs in apoE–/– mice on a Western diet by administration of a neutralizing antibody from week 6 until week 9.

Representative cross-sections are shown stained for: collagen (upper panels), lipids (middle panels), and macrophages (lower panels). Asterisks indicate the position of the atherosclerotic lesions. Bar diagrams represent quantification of the (immuno-)histological analysis of the different plaque components. The percentages of positive area at time point 9 weeks in the intima of the BCAs are indicated, comparing the control antibody group with the fractalkine antibody group. n = 6. *P < 0.05 versus control antibody group.